[{"id":"e4b8dc13-2fa4-4dfc-9ca2-9c244ab329af","acronym":"VX0120","url":"https://clinicaltrials.gov/study/NCT05901285","created_at":"2024-03-07T20:32:48.000Z","updated_at":"2025-02-25T15:13:32.267Z","phase":"Phase 1","brief_title":"Phase 1 Study of Intratumoral Administration of VAX014 in Subjects with Advanced Solid Tumors","source_id_and_acronym":"NCT05901285 - VX0120","lead_sponsor":"Vaxiion Therapeutics","biomarkers":" STING","pipe":"","alterations":" ","tags":["STING"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VAX014 intratumoral"],"overall_status":"Recruiting","enrollment":" Enrollment 32","initiation":"Initiation: 11/02/2023","start_date":" 11/02/2023","primary_txt":" Primary completion: 05/01/2026","primary_completion_date":" 05/01/2026","study_txt":" Completion: 05/01/2026","study_completion_date":" 05/01/2026","last_update_posted":"2025-02-13"}]